Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program
Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to its Board of Directors
Allurion Reports Lean Mass Gains with 14% Weight Loss
Allurion Presents at ASMBS Annual Meeting
Allurion Appoints Ojas A. Buch as COO
Allurion Expands AI Weight Loss Coach for GLP-1 Support
Allurion Presents at European Obesity Congress
Allurion Presents at IFSO-Europe 2024
Allurion Expands Virtual Care Suite to the United States
Brendan Gibbons Named Chief Legal Officer
Somerset NHS Treats First Patients with Allurion Balloon
Expanding Our Digital Platform with New Partnerships
Allurion Publishes Study on Improved Obesity Co-Morbidities
New Research Highlights GLP-1s' Impact
Allurion’s Digital Platform Expands with New Partnership
Allurion completes AUDACITY trial enrolment.
Allurion to Present Five Abstracts at Obesity Week 2023
Allurion at Oxford University World Congress
Allurion Presents Coach Iris: 24/7 AI Weight Loss Guide.
Allurion Presents Nine Abstracts at IFSO
Allurion Debuts as a Publicly Traded Company on the NYSE
Allurion Updates Board of Directors and Leadership
Allurion Showcases 20% Weight Reduction Data at 2023 ASMBS
Allurion Partners with Medtronic for AI Weight Loss Access.
Allurion to Participate in the Jefferies Healthcare Conference
Allurion & GLP-1 Study Showcased at European Obesity Congress
Allurion Shares Results from Remote Weight Loss Study
Allurion Unveils Premium Care Suite & 'My Daily Action' Bundle
Allurion Appoints Regina Barzilay, Ph.D. to Advisory Board
Allurion Named Champion Partner' of World Obesity Federation.
Allurion to Become Publicly Listed
Allurion's Training Gains SCOPE Accreditation
Allurion added to Deloitte List of Fastest Growing Companies
Allurion Receives Approval to Launch in Brazil
Allurion launches in India
Allurion Unveils Major Update to the Virtual Care Suite
Allurion Crosses 100,000 Patients Treated
Allurion Balloon Results In Significant Weight Loss
